Large-scale testing (Phase 3)Study completedNCT01869413What this trial is testingTranexamic Acid During Cystectomy Trial (TACT)Who this might be right forBladder Cancer Ottawa Hospital Research Institute 354
Not applicableStudy completedNCT03514888What this trial is testingHIPEC After Radical Cystectomy for High Risk Bladder CancerWho this might be right forInvasive Bladder Cancer Weill Medical College of Cornell University 7
Testing effectiveness (Phase 2)Study completedNCT01265940What this trial is testingPazopanib and Vinflunine in Urothelial Cancer of the BladderWho this might be right forAdvanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy. Prof. Dr. Thomas Otto 5
Early research (Phase 1)Active Not RecruitingNCT02496208What this trial is testingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsWho this might be right forBladder Small Cell Neuroendocrine CarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+27 more National Cancer Institute (NCI) 152
Testing effectiveness (Phase 2)Study completedNCT03558503What this trial is testingA Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder CancerWho this might be right forBladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder UroGen Pharma Ltd. 63
Large-scale testing (Phase 3)Not Yet RecruitingNCT07756008What this trial is testingBladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerWho this might be right forBladder Urothelial CarcinomaMuscle-invasive Bladder CancerBladder Cancer Tianjin Medical University Second Hospital 114
Testing effectiveness (Phase 2)Study completedNCT00238420What this trial is testingPaclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Urothelial CarcinomaStage I Bladder Cancer AJCC v6 and v7Stage II Bladder Cancer AJCC v6 and v7+1 more National Cancer Institute (NCI) 70
Not applicableUnknownNCT03577132What this trial is testingThe Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder CancerWho this might be right forUrothelial Carcinoma Seoul National University Hospital 20
Large-scale testing (Phase 3)Looking for participantsNCT07218380What this trial is testingVepugratinib (LY3866288) in Participants With Cancer in the Urinary TractWho this might be right forCarcinoma, Transitional CellUrinary Bladder NeoplasmsNeoplasm Metastasis Eli Lilly and Company 450
Testing effectiveness (Phase 2)Study completedNCT00397488What this trial is testingSunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT02710734What this trial is testingRisk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)Who this might be right forUrothelial Carcinoma of the Bladder Fox Chase Cancer Center 78
Testing effectiveness (Phase 2)Looking for participantsNCT07667335What this trial is testingEnfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial CancerWho this might be right forLocally Advanced Bladder Urothelial CarcinomaLocally Advanced Renal Pelvis Urothelial CarcinomaLocally Advanced Ureter Urothelial Carcinoma+10 more Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT02844816What this trial is testingAtezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder CancerWho this might be right forRecurrent Bladder Urothelial CarcinomaStage 0a Bladder Urothelial Carcinoma AJCC v6 and v7Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7+1 more National Cancer Institute (NCI) 172
Testing effectiveness (Phase 2)Study completedNCT03534804What this trial is testingCabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial CarcinomaWho this might be right forMetastatic Urothelial CarcinomaBladder Cancer University of Utah 37
Early research (Phase 1)Ended earlyNCT05839119What this trial is testingTargeting Androgen Signaling in Urothelial Cell Carcinoma - NeoadjuvantWho this might be right forUrothelial Carcinoma BladderAndrogen Receptor Positive Brown University 2
Early research (Phase 1)Looking for participantsNCT05833867What this trial is testingAdaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder CancerWho this might be right forLocalized Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma Shilpa Gupta, MD 20
Early research (Phase 1)Active Not RecruitingNCT00479128What this trial is testingBortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid TumorsWho this might be right forSolid TumorUrethral Cancer M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT02447549What this trial is testingStudy of Tumour Focused Radiotherapy for Bladder CancerWho this might be right forBladder Cancer Institute of Cancer Research, United Kingdom 345
Very early researchStudy completedNCT03039413What this trial is testingCopper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or BiopsyWho this might be right forBladder Urothelial CarcinomaUrothelial Carcinoma Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Testing effectiveness (Phase 2)Study completedNCT03219333What this trial is testingEnfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder CancerWho this might be right forCarcinoma, Transitional CellUrinary Bladder NeoplasmsUrologic Neoplasms+4 more Astellas Pharma Inc 219